Organon (OGN) Exchange Rate Effect (2020 - 2026)
Organon (OGN) recorded quarterly Exchange Rate Effect of -$31.0 million in Q1 2026, down 338.46% quarter-over-quarter from $13.0 million in Q4 2025, and down 170.45% on a YoY basis from $44.0 million in Q1 2025.
Organon (OGN) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Organon's Exchange Rate Effect history runs 7 years deep, the most recent figure standing at -$31.0 million for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 170.45% year-over-year to -$31.0 million; the TTM figure through Mar 2026 stood at $75.0 million (up 1037.5% YoY), while the FY2025 annual figure was $150.0 million, up 297.37% from the prior year.
- Exchange Rate Effect was -$31.0 million for Q1 2026 at Organon, down from $13.0 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $93.0 million in Q2 2025 to a low of -$100.0 million in Q4 2024.
- Historically, Exchange Rate Effect has averaged $1.5 million across 5 years, with a median of -$7.0 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect tumbled 3500.0% in 2022, then surged 504.35% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at $83.0 million in 2022, then sank by 51.81% to $40.0 million in 2023, then sank by 350.0% to -$100.0 million in 2024, then soared by 113.0% to $13.0 million in 2025, then plunged by 338.46% to -$31.0 million in 2026.
- The last three Exchange Rate Effect figures came in at -$31.0 million (Q1 2026), $13.0 million (Q4 2025), and $93.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn | 2.70 Mn |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn | 67.00 Mn |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn | -25.00 Mn |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn | -12.00 Mn |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn | -19.00 Mn |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | -11.00 Mn |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn | 19.00 Mn |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn | -48.00 Mn |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn | -31.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.00 Mn |
| Mar 31, 2026 | -31.00 Mn |
| Dec 31, 2025 | 13.00 Mn |
| Dec 31, 2025 | 13.00 Mn |
| Jun 30, 2025 | 93.00 Mn |
| Jun 30, 2025 | 93.00 Mn |
| Mar 31, 2025 | 44.00 Mn |
| Mar 31, 2025 | 44.00 Mn |
| Dec 31, 2024 | -100.00 Mn |
| Dec 31, 2024 | -100.00 Mn |
| Sep 30, 2024 | 71.00 Mn |
| Sep 30, 2024 | 71.00 Mn |
| Jun 30, 2024 | -23.00 Mn |
| Jun 30, 2024 | -23.00 Mn |
| Mar 31, 2024 | -24.00 Mn |
| Mar 31, 2024 | -24.00 Mn |
| Dec 31, 2023 | 40.00 Mn |
| Dec 31, 2023 | 40.00 Mn |
| Sep 30, 2023 | -40.00 Mn |
| Sep 30, 2023 | -40.00 Mn |